SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 12th, 2018 • Premier Biomedical Inc • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of March 1, 2018, between Premier Biomedical, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 12th, 2018 • Premier Biomedical Inc • Biological products, (no disgnostic substances)
This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 1, 2018, between Premier Biomedical Inc., a Nevada corporation (the “Company”), and the purchasers signatory hereto (each a “Holder” and collectively the “Holders”).
8% CONVERTIBLE PROMISSORY NOTE DUE MAY 31, 2018Premier Biomedical Inc • April 12th, 2018 • Biological products, (no disgnostic substances) • New York
THIS 8% CONVERTIBLE PROMISSORY NOTE is a duly authorized and validly issued 8% Convertible Promissory Note of Premier Biomedical, Inc. (the “Company”), having its principal place of business at P.O. Box 25, Jackson Center, PA 16133, designated as its 8% Convertible Note due May 31, 2018 (this Note, the “Note” and, collectively with the other Notes of such series, the “Notes”).
